Fast CD4 count increase.
Stimulates Th1, Th9 and Th17 that can lead to the elimination of HIV virus.
Remedies the opportunistic infection symptoms by boosting your immune system.
Reduce the side effects caused by antiretroviral drugs.
Improves your quality of life, enabling you to live a normal life.
As a result of our research, we have developed an evolving range of products formulated from natural plant extracts to alleviate problems caused by an imbalance in the immune system commonly associated with HIV.
LIV capsules is a part of Operation BIM products which are the results of more than 30 years of research conducted by our Research and Development Team at the Asian Phytoceuticals Public Co. Ltd. (APCO). The breakthrough came in 2008 when our team of scientists and researchers were able to successfully develop a 100% natural plant-based supplement that contained Centella asiatica juice powder, black sesame extract, isolated soy protein extract, guava fruit juice powder, and mangosteen aril extract.e.
Once a patient is infected with HIV, the virus penetrates into specific white blood cells known as CD4 cells and hides in white blood cells, making it difficult to detect and kill. Based on research from 2012-2013, the type of CD4 cells that HIV destroys the most is the TH17 which are an essential part of the immune system. HIV patients do not die from HIV. Because their immune system is weakened by HIV, they will be susceptible to other opportunistic diseases caused by bacteria, fungi, and other viruses.
APCO Scientists have developed LIV that stimulates Th17, TH1, and Th9 by 500%, 200%, and 200% respectively. All the stimulated TH cells increase the activities of natural killer cells and cytotoxic T-cells that eliminate HIV.
Results of the LIV efficiency test carried out at the Biomedical Technology Research Centre, Chaing Mai University.
At Baan Gerda Children’s Rights Foundation, APCO has given capsules to HIV-infected children who were taking antiretroviral drugs and suffering from opportunistic diseases. These results are based on 70 children over the course of 10 years.
After taking 4 LIV capsules for 12 months, the opportunistic diseases symptoms were remedied and their CD4 count increased by an average of 67.34%
A group of children who were already taking antiretroviral drugs but whose CD4 count had not increased for the previous 6 months had an average increase of 32.4% in their CD4 count after taking 9 LIV capsules for 3 months.